For instance, in human hepatocellular carcinoma (HCC), there is an increased frequency of AZIN1 editing at residue 367 (Ser to Gly), leading to inhibition of antizyme tumor-suppressor function and contributing to cancer initiation and progression [5]. Here, AZIN1 is linked to hepatocellular carcinoma.